10
Dec
Dec
Retatrutide peptide (LY3437943) is an investigational triple-hormone receptor agonist being developed by Eli Lilly and Company. It is not a simple peptide but a single synthetic peptide molecule engineered to simultaneously target three key metabolic receptors:GLP-1 Receptor (Glucagon-like peptide-1) – Increases insulin, decreases glucagon, slows gastric emptying, promotes satiety.GIP Receptor (Glucose-dependent insulinotropic polypeptide) – Enhances insulin secretion and may improve fat […]